Utility of γ-Glutamyl Transferase in Predicting Troponin Elevation in Emergency Departments

Selami Demirelli1, Serdar Firtina2, Lutfu Askin3

  • 1Department of Cardiology, Erzurum Education and Research Hospital, Erzurum, Turkey demirelli23@yahoo.com.

Angiology
|October 31, 2015
PubMed

Insights

Serum gamma-glutamyl transferase (GGT) can help predict high troponin levels in acute coronary syndrome (ACS) patients. Higher GGT activity was linked to troponin positivity, suggesting its complementary role in diagnosis.

Area of Science:

  • Cardiology
  • Biochemistry

Background:

  • Serum gamma-glutamyl transferase (GGT) is a known risk predictor for coronary artery disease.
  • Elevated GGT levels are associated with increased cardiovascular morbidity and mortality.

Purpose of the Study:

  • To evaluate the clinical utility of GGT activity in predicting high troponin levels in patients with acute coronary syndrome (ACS).
  • To assess GGT as a potential complementary biomarker for troponin positivity in emergency department patients presenting with chest pain.

Main Methods:

  • Cross-sectional study involving 403 patients (200 troponin-positive, 203 troponin-negative) admitted with chest pain.
  • Measurement of serum GGT activity and troponin levels.
  • Statistical analysis including logistic regression and Spearman rank correlation.

Main Results:

  • GGT activity was significantly higher in troponin-positive patients (44 ± 34 U/L) compared to troponin-negative patients (31 ± 26 U/L, P = .001).
  • A GGT cutoff of >25.5 U/L demonstrated 62% sensitivity and 61% specificity for predicting troponin positivity.
  • Logistic regression confirmed a significant predictive value of GGT for troponin positivity, with a moderately strong correlation.

Conclusions:

  • Elevated serum GGT activity is a significant predictor of troponin positivity in ACS patients presenting with chest pain.
  • GGT may serve as a valuable, accessible biomarker to complement troponin testing in the emergency setting.
  • Further research can explore GGT's role in risk stratification and early diagnosis of acute coronary events.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
426
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.1K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
487